Testosterone replacement therapy in relation with cardiovascular disease in cisgender women and transgender people.

David S Lopez,Juwairia S Mulla,Danielle El Haddad,Md Ibrahim Tahashilder,Efstathia Polychronopolou,Jacques Baillargeon,Yong-Fang Kuo,Syed Gilani,Wissam I Khalife

The Journal of clinical endocrinology and metabolism（2023）

引用 0|浏览6

暂无评分

摘要

Use of TTh increased the risk of CVD, CAD and stroke among is cisgender women, but not among transgender people. TTh is becoming more widely accepted in women, and it is the main medical treatment for transgender males. Therefore, use of TTh should be further investigated for the prevention of CVD.

查看译文

关键词

testosterone, cardiovascular, women, transgender

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要